According to study, “World Membrane Oxygenator Market Research Report 2024(covering USA, EU, China, South East Asia, Japan and etc)” the key companies operating in the world membrane oxygenator market areMedosMedizintechnik AG,Eurosets S.R.L., WEGO, Sorin Group,Kewei (Microport), Xijian Medical,Abbott Pvt Ltd., Getinge Group, Shanghai Microport Orthopedics, Alung Technologies Inc., Medtronic Plc,Nipro Medical Corp., Terumo Cardiovascular Systems,Xenios AG, Origen Biomedical Inc., Fresenius Medical Care AG & Co. KGaA, Siemens AG, Agilent Technologies, MAQUET Holding B.V. & Co. KG, BraileBiomedica, Livanova Plc, Chalice Medical.The key players are focusing on product launches, agreements, approvals, partnerships, expansions, and acquisitions to increase their product portfolios & customer bases, augment their sales channels, and proliferation their global presence.
Membrane oxygenator is a device or machine used to add oxygen and remove carbon dioxide from the blood. It is used in two principal modes: to oxygenate blood in longer term life support and to imitate the function of the lungs in cardiopulmonary bypa (CPB). It is also termed as life support machine and Extracorporeal membrane oxygenation machine (ECMO). It is used in the treatment of several heart & lung disease. Its main function is to provide enough oxygen to the body when heart & lung are not functioning properly. Some of the risk included infections, bleeding, and technical failures.
Based on type, membrane oxygenator market is segmented into hollow fiber membrane oxygenat or and flat sheet membrane oxygenator. Based on component, market is segmented into pumps (centrifugal pumps & roller pumps), controllers, oxygenators, accessories and cannula. The pumps segment is expected to be the fastest-growing owing to increase in incidences of asthma. Based on modality, market is segmented into Veno-Venous (VV), Veno-Arterial (VA) and Arterio-Venous (AV). Modalities are used to provide hemodynamic support & to help gaseous exchange in patients with cardiac or respiratory failure. The VA segment is anticipated to hold a major share in the market as a result of its widespread use in the treatment of cardiovascular collapse. Based on application, market is segmented into cardiac, respiratory and Extracorporeal Cardiopulmonary Resuscitation (ECPR). Cardiac application includes pediatric, neonates and adults. In addition, based on end-use, market is segmented into pediatric, neonates and adults.
The membrane oxygenator market is driven by rise in incidence in Chronic Obtrusive Pulmonary Diseases (COPD), followed by increase in incidences of cardiac disorders, rise in adoption of ECMO machines, increase in investment in research & development (R&D) of new medical devices, favorable reimbursement scenario, growth in awareness about health disorder, rise in tobacco consumption and growth in technological advancements. However, presence of alternative techniques, risks associated with ECMO treatment and high cost of ECMO procedures may impact the market. Moreover, increase in survival rates with ECMO is a key opportunity for market.
Based on geography, USA country holds major share, followed by EU, inmembrane oxygenator market owing to increase in technological acceptance, rise in availability of state-of-the-art health facilities and high investment in research & development. India and China countries are expected to witness higher growth rate due to increase in prevalence of respiratory illnesses, and growth in development of health infrastructure over the forecast period. It is projected that market will be reached at rapid pace on account of new product development & technological advancements over the forecast period.
For more information on the research report, refer to below link:
World Membrane Oxygenator Market Research Report
Related reports
Global Membrane Oxygenator Market Analysis 2013-2018 and Forecast 2019-2024
Contact Us:-
Ken Research
Ankur Gupta, Head Marketing & Communications
+91-9015378249
